Dow Up 0.11% Nasdaq Up 0.50%

United Therapeutics Corporation (UTHR)

-NasdaqGS
117.83 Up 26.14(28.51%) Aug 29, 3:59PM EDT
|After Hours : 117.50 Down 0.33 (0.28%) Aug 29, 7:58PM EDT
Prev Close:91.69
Open:92.17
Bid:N/A
Ask:119.00 x 200
1y Target Est:111.86
Beta:1.7
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:90.40 - 118.76
52wk Range:70.95 - 118.76
Volume:6,443,280
Avg Vol (3m):746,600
Market Cap:5.57B
P/E (ttm):25.60
EPS (ttm):4.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
UTHRUp 28.51%5.57B
GILDUp 0.05%162.60B
PFEUp 0.03%186.36B

Key Statistics

Forward P/E (1 yr):12.06
P/S (ttm):3.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.55
Quarterly EPS Est (Sep-14) :1.98
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):2.76

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback